Це відео не доступне.
Перепрошуємо.

Transcatheter Mitral Valve Repair: Current Status and Ongoing Clinical Trials (Saibal Kar, MD)

Поділитися
Вставка
  • Опубліковано 15 лис 2023
  • Dr. Karr talks in detail about the current outcomes and ongoing clinical trials of transcatheter mitral valve repair.
    Objectives:
    1. Review the current indications for transcatheter mitral valve regurgitation.
    2. Review the current literature supporting indications.
    3. Overview of ongoing clinical trial expansion of indications.
    ** This medical education program may contain graphic content. **
    _________________________________
    A DeBakey CV Education event
    Presented by Houston Methodist DeBakey Heart & Vascular Center.
    Building on Dr. Michael E. DeBakey’s commitment to excellence in education, Houston Methodist DeBakey CV Education is an epicenter for cardiovascular academic and clinical educational programs that support the provision of optimal care to patients suffering from cardiovascular conditions and diseases.
    FOR MORE INFORMATION
    DeBakey CV Education:
    www.houstonmet...
    For the latest education and training opportunities from DeBakey CV Education: bit.ly/HMdebake...
    Follow Us:
    Twitter: / debakeycvedu
    Livestream: livestream.com...
    SmugMug: debakey.smugmu...
    Want concise, relevant reviews of the hottest topics in CV medicine? Subscribe for FREE to the Methodist DeBakey Cardiovascular Journal for quarterly, peer-reviewed issues delivered to your door.
    journal.housto...

КОМЕНТАРІ • 2

  • @jasonyang3029
    @jasonyang3029 8 місяців тому

    I strongly advocate for mitral valve repair over the use of the Mitral clip, as surgical repair offers a more functional and physiologically effective restoration of mitral valve function.

    • @RememberWhoUAreSimba
      @RememberWhoUAreSimba 8 місяців тому +1

      EVEREST II shows that a percutaneous first option is safe, with less adverse events than upfront surgical option for primary MR. Worst case, surgery down the road in about 20% of patients treated with clip.
      For Secondary MR, there is 0 data to support surgery at all, where as MitraClip is a historically beneficial intervention.